4-[4-(4-{[(4-{[2-(dimethylamino)ethyl](methyl)carbamoyl}phenyl)carbamoyl]amino}phenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]-N,N-dimethylpiperazine-1-carboxamide | 1197167-25-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 4-[4-(4-{[(4-{[2-(dimethylamino)ethyl](methyl)carbamoyl}phenyl)carbamoyl]amino}phenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]-N,N-dimethylpiperazine-1-carboxamide
• 英文别名: 4-[4-[4-[[4-[2-(dimethylamino)ethyl-methylcarbamoyl]phenyl]carbamoylamino]phenyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-N,N-dimethylpiperazine-1-carboxamide
• CAS: 1197167-25-1
• 化学式: C₃₃H₄₅N₁₁O₄
• 分子量: 659.792
• InChiKey: CTYDFOLTGPJGIM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  48
• 可旋转键数：
  9
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  143
• 氢给体数：
  2
• 氢受体数：
  10

文献信息

• TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS
  申请人：Venkatesan Aranapakam Mudumbai

  公开号：US20090291079A1

  公开（公告）日：2009-11-26

  Compounds of formula I wherein: R 1 is and R 2 , R 4 , and R 6-9 are defined herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase and mTOR, such as a variety of cancers. Methods for making and using the compounds of this invention are disclosed. Various compositions containing the compounds of this invention are also disclosed.

  化合物I的公式如下：其中：R1是定义如下的基团，R2，R4和R6-9在此处被定义，以及其药学上可接受的盐和酯。这些化合物抑制PI3激酶和mTOR，并可用于治疗由PI3激酶和mTOR介导的疾病，如各种癌症。本发明揭示了制备和使用这些化合物的方法。还揭示了含有这些化合物的各种组合物。
• [EN] TRIAZINE COMPOUNDS AS P13 KINASE AND MTOR INHIBITORS<br/>[FR] COMPOSÉS TRIAZINES EN TANT QU'INHIBITEURS DE KINASE P13 ET DE MTOR
  申请人：WYETH CORP

  公开号：WO2009143313A1

  公开（公告）日：2009-11-26

  Compounds of formula I (I) wherein: R1 is (II) or (III); and R2, R4, and R6-9 are defined herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase and mTOR, such as a variety of cancers. Methods for making and using the compounds of this invention are disclosed. Various compositions containing the compounds of this invention are also disclosed.

  式I的化合物（I）其中：R1为（II）或（III）; R2、R4和R6-9在此定义，并且其药学上可接受的盐和酯。这些化合物抑制PI3激酶和mTOR，并可用于治疗由PI3激酶和mTOR介导的疾病，如各种癌症。公开了制备和使用本发明化合物的各种方法。还公开了含有本发明化合物的各种组合物。
• TRIAZINE COMPOUNDS AS P13 KINASE AND MTOR INHIBITORS
  申请人：Wyeth LLC

  公开号：EP2294072A1

  公开（公告）日：2011-03-16
• US8039469B2
  申请人：——

  公开号：US8039469B2

  公开（公告）日：2011-10-18
• US8217036B2
  申请人：——

  公开号：US8217036B2

  公开（公告）日：2012-07-10